Symptom Library
18 common perimenopause symptoms with approximate prevalence, the physiological mechanism behind each one, what the evidence says helps, and the findings that need medical review rather than reassurance.
Approximate prevalence
≈ 75–80% of women
Why it happens
Falling oestrogen narrows the hypothalamic thermoneutral zone and upregulates KNDy neurons in the temperature-control centre. A small rise in core temperature that would previously go unnoticed now triggers a full heat-dissipation response — flushing, sweating and skin vasodilation.
What the evidence says helps
Layered clothing, cool ambient temperature, and identifying personal triggers (alcohol, caffeine, spicy food, warm rooms). Where symptoms are bothersome, hormone therapy is the most effective treatment; SSRIs, SNRIs, gabapentin and the newer neurokinin-3 antagonists are alternatives. CBT reduces the distress and impact of flushes even when frequency is unchanged.
See a clinician if
Symptoms are disrupting sleep, work or daily life. Effective treatment exists — persisting without it is not necessary.
Approximate prevalence
Very common alongside flushes
Why it happens
The same thermoregulatory mechanism as hot flushes, occurring during sleep. Because each episode causes a partial awakening, night sweats fragment sleep architecture even when a woman does not fully wake — which is why daytime fatigue can be severe despite apparently adequate hours in bed.
What the evidence says helps
A cool bedroom, breathable natural-fibre bedding and layered nightwear that can be removed. Reducing alcohol in the evening has a measurable effect. Treating the underlying vasomotor symptoms usually resolves the sleep disruption too.
See a clinician if
Sleep is repeatedly disrupted. Also mention drenching night sweats with weight loss or fever, which need separate investigation.
Approximate prevalence
Near-universal during the transition
Why it happens
As the follicle pool depletes, ovulation becomes intermittent. Cycles typically shorten first, then become variable by seven days or more, and eventually skip. Anovulatory cycles produce little progesterone, so the endometrium is exposed to unopposed oestrogen — which is why bleeding can become notably heavier before it stops.
What the evidence says helps
Tracking cycle length and flow gives your clinician the single most useful piece of information for staging the transition. Heavy bleeding is treatable — the levonorgestrel intrauterine system, tranexamic acid and hormonal options are all effective.
See a clinician if
Bleeding between periods, after sex, soaking through protection hourly, lasting beyond seven days, or any bleeding at all after twelve months without a period. Postmenopausal bleeding always requires investigation.
Approximate prevalence
≈ 40–60% report cognitive change
Why it happens
Oestrogen receptors are dense in the hippocampus and prefrontal cortex, and oestrogen supports glucose metabolism and synaptic function in those regions. Measurable dips in verbal memory and processing speed occur during perimenopause. Sleep fragmentation compounds the effect substantially.
What the evidence says helps
Sleep is the highest-yield target — treating night sweats and insomnia often improves cognition markedly. Aerobic and resistance exercise, reducing alcohol, and managing vasomotor symptoms all contribute. Reassuringly, longitudinal data indicate cognitive performance generally recovers after the transition.
See a clinician if
Cognitive change is progressive, affects orientation or word-finding severely, or is out of proportion to other symptoms — thyroid function, B12, iron and mood should be assessed.
Approximate prevalence
Commonly reported; often new-onset
Why it happens
Oestrogen modulates serotonin and noradrenaline signalling, while progesterone's metabolite allopregnanolone acts on GABA-A receptors — the same target as anxiolytic medication. When both fluctuate unpredictably, the nervous system loses a stabilising input. New-onset anxiety in the early forties, without a corresponding life stressor, is a recognised presentation.
What the evidence says helps
Understanding the biological basis is genuinely therapeutic — many women describe relief simply at being told it is not a character failing. CBT has strong evidence. Regular exercise, reduced caffeine and alcohol, and treating sleep disruption all help. Where symptoms are hormonally driven, hormone therapy may improve them; where they are established, SSRIs or SNRIs may be more appropriate.
See a clinician if
Anxiety is affecting your functioning or relationships, includes panic attacks, or comes with low mood. Both hormonal and psychological contributions should be assessed — not one instead of the other.
Approximate prevalence
Risk approximately doubles
Why it happens
Longitudinal cohorts show the risk of clinically significant depressive symptoms roughly doubles during the menopause transition compared with the premenopausal years. Vulnerability is higher in women with previous depression, premenstrual mood sensitivity, or postnatal depression — a history of hormone-sensitive mood change is the strongest predictor.
What the evidence says helps
Effective options include psychological therapy, antidepressants, and — for mood that is clearly linked to the hormonal transition — hormone therapy, which has evidence for depressive symptoms in perimenopause specifically. Exercise and sleep treatment are meaningful adjuncts.
See a clinician if
Promptly, if mood is persistently low, you have lost interest in things you valued, or you have any thoughts of self-harm. This is treatable and should not be waited out.
Approximate prevalence
Among the most commonly reported
Why it happens
Rapid oestrogen fluctuation destabilises the neurotransmitter systems governing emotional regulation, while intermittent ovulation removes the steadying influence of progesterone. Women frequently describe reactions that feel disproportionate and out of character — the change in emotional threshold is real, not imagined.
What the evidence says helps
Naming the hormonal connection reduces the self-blame that often accompanies these symptoms. Consistent sleep, regular exercise, reduced alcohol, and treating co-occurring vasomotor symptoms all help. Cycle tracking alongside mood often reveals a pattern that guides treatment.
See a clinician if
Irritability is damaging relationships or work, or is accompanied by persistent low mood or anxiety.
Approximate prevalence
≈ 40–60% during the transition
Why it happens
Two mechanisms operate together. Declining progesterone reduces allopregnanolone-mediated GABA activity, which directly disturbs sleep architecture. Separately, night sweats fragment sleep. Many women wake reliably in the early hours — a pattern that often appears before any other recognised symptom.
What the evidence says helps
CBT for insomnia is the recommended first-line treatment and outperforms sedatives over the long term. Consistent sleep and wake times, a cool dark room, no alcohol within three hours of bed, and limiting late caffeine all matter. Treating night sweats where present is essential.
See a clinician if
Sleep problems persist beyond a few weeks. Mention loud snoring, witnessed pauses in breathing, or unrefreshing sleep despite adequate hours — obstructive sleep apnoea rises after menopause and is frequently missed in women.
Approximate prevalence
≈ 50–70% postmenopause
Why it happens
The vulva, vagina, urethra and bladder are all oestrogen-dependent. Reduced oestrogen thins the epithelium, decreases blood flow and elasticity, and raises vaginal pH — together termed genitourinary syndrome of menopause. Unlike hot flushes, this is progressive: it does not improve with time and typically worsens without treatment.
What the evidence says helps
Non-hormonal vaginal moisturisers used regularly (not only before sex) and good lubricants help symptomatically. Low-dose vaginal oestrogen is highly effective, has minimal systemic absorption, does not require added progestogen, and can generally be continued long-term. Vaginal DHEA and oral ospemifene are alternatives where available.
See a clinician if
Raise it — this is among the most treatable and most under-treated symptoms in medicine. Also report bleeding, unusual discharge, or recurrent urinary tract infections.
Approximate prevalence
Common and under-reported
Why it happens
The urethra and bladder trigone share the same oestrogen dependence as vaginal tissue. Declining oestrogen contributes to urgency, increased frequency, nocturia and recurrent urinary tract infections. Pelvic floor changes from earlier childbirth often become symptomatic in this period as tissue support reduces.
What the evidence says helps
Low-dose vaginal oestrogen reduces recurrent urinary tract infections and improves urgency. Supervised pelvic floor muscle training has strong evidence for stress incontinence and should be offered before surgical options. Bladder training helps urgency.
See a clinician if
Any blood in the urine, pain on passing urine, recurrent infections, or incontinence affecting your daily life. None of this is an inevitable consequence of age.
Approximate prevalence
Very commonly reported
Why it happens
Usually multifactorial: fragmented sleep, the metabolic effects of falling oestrogen, iron deficiency from heavy perimenopausal bleeding, and mood symptoms compounding one another. Fatigue that does not improve with rest is the presentation most likely to be dismissed and most likely to have a treatable cause.
What the evidence says helps
Address sleep first, since it is usually the largest single contributor. Regular exercise improves fatigue despite feeling counterintuitive. Where periods have been heavy, iron studies are important — iron deficiency without anaemia still causes significant fatigue.
See a clinician if
Fatigue is significant or persistent. Reasonable baseline tests include full blood count, ferritin, thyroid function, HbA1c and vitamin D.
Approximate prevalence
Reported by roughly half of women
Why it happens
Oestrogen has anti-inflammatory activity and receptors are present in joint tissue, cartilage and tendon. Falling levels are associated with new or worsening aches, morning stiffness and tendon problems — frequently in hands, knees, shoulders and hips. Frozen shoulder shows a notable peak in this age group.
What the evidence says helps
Progressive resistance training is the strongest intervention — it addresses joint pain, muscle mass and bone density simultaneously. Low-impact aerobic activity, adequate protein, and maintaining a healthy weight all help. Some women report improvement in joint symptoms on hormone therapy.
See a clinician if
Pain is localised to one joint with swelling, redness or heat; there is morning stiffness lasting over an hour; or symptoms are progressive — inflammatory arthritis also commonly presents in this age group in women.
Approximate prevalence
Body composition change is near-universal
Why it happens
Two distinct processes are often conflated. Age-related loss of muscle mass reduces resting metabolic rate. Separately, falling oestrogen shifts fat storage from hips and thighs toward the abdomen and reduces insulin sensitivity. Visceral fat gain can therefore occur even at stable weight — which is why the scale can mislead.
What the evidence says helps
Resistance training is the highest-yield intervention because it preserves the muscle mass driving metabolic rate. Adequate protein supports that. Reducing alcohol helps sleep, visceral fat and vasomotor symptoms together. Restrictive dieting tends to accelerate muscle loss and is counterproductive here.
See a clinician if
Weight change is rapid or unexplained. Given rising cardiometabolic risk across the transition, blood pressure, lipids and HbA1c are worth checking regardless.
Approximate prevalence
Commonly reported, often with flushes
Why it happens
Oestrogen influences vascular tone and autonomic regulation. Palpitations frequently accompany the sympathetic surge of a hot flush, and many women notice them most at night. They are usually benign in this context — but that determination belongs to a clinician, not to a website.
What the evidence says helps
Reducing caffeine, alcohol and nicotine; managing stress; maintaining hydration. Treating vasomotor symptoms often reduces flush-associated palpitations.
See a clinician if
Always mention palpitations. Seek urgent assessment for palpitations with chest pain, breathlessness, fainting or near-fainting, or a persistently fast irregular pulse — atrial fibrillation becomes more common with age and is treatable.
Approximate prevalence
Frequently reported
Why it happens
Rarely a single cause. Androgen levels decline gradually with age, but the larger contributors are usually pain from genitourinary changes, fatigue, disrupted sleep, low mood, medication effects (notably SSRIs) and relationship context. Treating pain and exhaustion often restores desire without any hormonal intervention aimed at libido itself.
What the evidence says helps
Address the contributors first — vaginal comfort, sleep, mood, and reviewing medications. Psychosexual therapy has good evidence. Where distressing low desire persists after those are addressed, the 2019 Global Consensus Position Statement supports a trial of testosterone in postmenopausal women, though it is off-label in most countries.
See a clinician if
It is affecting your wellbeing or relationship, or sex is painful. Painful sex has a specific, effective treatment and should never be accepted as normal.
Approximate prevalence
Often worsen during perimenopause
Why it happens
Migraine is strongly oestrogen-sensitive, and it is oestrogen withdrawal rather than absolute level that most reliably triggers attacks. The erratic swings of perimenopause therefore often worsen existing migraine or produce it for the first time. Many women improve after menopause once levels stabilise.
What the evidence says helps
Consistent sleep and meals, hydration, and identifying personal triggers. Where hormone therapy is used, continuous transdermal delivery is generally preferred over cyclical or oral routes because it avoids the withdrawal peaks that provoke attacks. Standard migraine preventives remain appropriate.
See a clinician if
Headache is sudden and severe, differs in character from your usual pattern, comes with visual loss, weakness, confusion or fever, or wakes you from sleep. Migraine with aura is also relevant to contraceptive and hormone therapy choices, so mention it explicitly.
Approximate prevalence
Very common
Why it happens
Oestrogen supports collagen synthesis, skin hydration and the hair growth phase. Skin collagen declines measurably in the years around menopause, causing dryness and reduced elasticity. Scalp hair may thin diffusely as the relative androgen balance shifts, while facial hair can increase for the same reason.
What the evidence says helps
Consistent emollients and daily sun protection; adequate protein and iron; gentle hair handling. Confirmed iron or thyroid deficiency should be corrected. Topical minoxidil has evidence for female pattern hair loss.
See a clinician if
Hair loss is rapid, patchy, or associated with scalp scarring or inflammation — these have different causes and treatments. Ferritin and thyroid function are worth checking.
Approximate prevalence
Under-recognised
Why it happens
Oral mucosa is oestrogen-responsive. Reduced oestrogen is associated with dry mouth, burning mouth sensation, altered taste, and increased susceptibility to gum inflammation. Reduced saliva also raises decay risk. This connection is rarely mentioned to women and often surprises them.
What the evidence says helps
Diligent oral hygiene, staying hydrated, sugar-free saliva substitutes for dry mouth, and telling your dentist you are in the menopause transition so care can be adjusted.
See a clinician if
See a dentist for persistent dry mouth, bleeding gums or oral pain. Report any mouth ulcer that has not healed within three weeks.
Sources
Prevalence and mechanism drawn from the SWAN longitudinal cohort, NICE guideline NG23 (Menopause: identification and management), The Menopause Society 2022 position statement on hormone therapy, and the 2019 Global Consensus Position Statement on testosterone therapy for women. Figures are approximate and differ across populations, definitions and study designs. Medicine availability, licensing and brand names vary by country.
Want to go deeper?
Our topic guides explain the underlying mechanisms in more detail.